Strategic Growth TDS has expanded through strategic mergers and acquisitions, including the 2022 acquisition of PrescribeWellness and the 2023 merger with Outcomes, expanding its nationwide pharmacy network and patient engagement capabilities. This signals openness to integrating complementary technologies and services, presenting opportunities to cross-sell enhanced patient engagement, CRM, and data analytics offerings.

Network leverage With a large install base across all 50 states and the Virgin Islands and a combined network of tens of thousands of pharmacy locations (including outcomes from the merger), TDS provides a ready distribution channel for new software modules, services, and supportive technologies that integrate into existing pharmacy workflows.

Patient engagement Recent product updates such as Opportunities Now and the focus on patient-centric solutions position TDS as a potential partner for additional patient relationship management tools, outreach automation, and engagement analytics that can be layered onto their current platform to boost refill rates and adherence programs.

Healthcare partnerships Strategic collaborations with Cardinal Health and other ecosystem players indicate a willingness to integrate with larger healthcare networks and wholesalers. This creates sales opportunities for interoperability connectors, data integration, and workflow integrations with hospital and retail networks.

Financial scale Revenue in the mid tens of millions range with a sizable employee base suggests capacity to adopt scalable, cloud-based SaaS modules and managed services at varying price points. There is opportunity to upsell managed services, security, compliance, and data analytics offerings tailored to independent and multi-location pharmacies.